Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin vs Rosuvastatin in HFrEF
NCT05072054Phase 4Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in heart failure with reduced ejection fraction (HFrEF), sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05072054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05072054.